TELA Bio (TELA) Total Debt Growth (1y) (2019 - 2026)
TELA Bio (TELA) Total Debt Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 19.06% |
| 10 | TELA Bio | 38.24 Mn | -1.30 Mn | 12.52 Mn | 35.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.35% |
| Dec 31, 2025 | 35.33% |
| Sep 30, 2025 | 1.28% |
| Jun 30, 2025 | 1.39% |
| Mar 31, 2025 | 1.50% |
| Dec 31, 2024 | 1.50% |
| Sep 30, 2024 | 1.50% |
| Jun 30, 2024 | 1.50% |
| Mar 31, 2024 | 1.50% |
| Dec 31, 2023 | 1.50% |
| Sep 30, 2023 | 1.50% |
| Jun 30, 2023 | 1.50% |
| Mar 31, 2023 | 26.51% |
| Dec 31, 2022 | 26.75% |
| Sep 30, 2022 | 26.99% |
| Jun 30, 2022 | 27.20% |
| Mar 31, 2022 | 2.22% |
| Dec 31, 2021 | 2.15% |
| Sep 30, 2021 | 2.09% |
| Jun 30, 2021 | 2.03% |